Apr 09, 2019
Global Antiretroviral Drugs Market 2013-2019 & 2023 - Multi-Class Drug Combinations are Predicted to Hold their Dominant Position in the Market
Apr 08, 2019
FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment
Mar 07, 2019
Janssen Announces Results Of Two Phase 3 Studies Which Showed Long-Acting Injectable HIV Treatment Regimen Of Rilpivirine And Cabotegravir Demonstrated Comparable Safety And Efficacy To Daily Oral HIV Therapy
Feb 20, 2019
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019-2025 with AbbVie, Merck, Gilead Sciences, Bristol-Myers Squibb, Janssen & GSK Dominating
Dec 21, 2018
Viriom to Report Results from Phase 1b Clinical Trial of Once Weekly Oral HIV Treatment
Nov 15, 2018
Global HIV Diagnostics and Therapeutics Markets Report 2018-2023 Featuring Abbott Laboratories, Bio-Rad Laboratories, Cipla, GSK, Merck & Co., Siemens Healthineers and Thermo Fisher Scientific
Oct 31, 2018
Zion Medical Announces Results of First Human Clinical Trial of HIV drug Gammora, Offering Potential Cure
Sep 20, 2018
First Patient Included into ISR's Phase IIa HIV Study
Aug 15, 2018
Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1
Jul 24, 2018
Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA(TM) (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
Jul 20, 2018
Global HIV Drugs Market 2018-2023: Key Players are Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson & Merck
Jul 17, 2018
Janssen Announces U.S. FDA Approval of SYMTUZA(TM) (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
May 24, 2018
The Medicines Patent Pool Presents New Five-Year Strategy for Improving Access to Priority Treatments in Developing Countries
May 02, 2018
The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network
Apr 04, 2018
PlushCare Serves Over 1,000 PrEP Patients Via Virtual Care
Mar 28, 2018
Mylan Introduces Symfi(TM) Triple Combo Once-Daily HIV Treatment in the U.S.
Mar 13, 2018
Targeting HIV: Moving closer to a potential cure
Mar 06, 2018
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo(TM) (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1
Mar 06, 2018
FDA approves new HIV treatment for patients who have limited treatment options
Mar 02, 2018
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.